PI3Kβ (p110β/p85α) Assay Kit

Catalog #
79802
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PI3Kβ (p110β/p85α) Assay Kit is designed to measure PI3Kβ activity for screening and profiling applications, using ADP-Glo® Kinase Assay as a detection reagent.

Need us to run inhibitor screens or profile your compounds against PI3Kβ (p110β/p85α)? Check out our Kinase Screening Services.

Synonyms
PIK3CB, p110beta, Phosphoinositide-3-Kinase Catalytic Beta

PIK3R1, Phosphoinositide-3-Kinase Regulatory Subunit 1 (Alpha), GRB1, p85alpha, PI3K, pi3k

Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Species
Human
Supplied As
The PI3Kβ (p110β/p85α) Assay Kit comes in a convenient 96-well format, with enough purified recombinant PI3Kβ enzyme, PI3K lipid substrate, ATP and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied
  • ADP-Glo® Kinase Assay (Promega #V6930)
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Reagent Amount Storage
40622 PI3Kβ (p110β/p85α) 5 µg -80°C Avoid
mutiple
freeze/ thaw
cycles!
79334 5x Kinase assay buffer 1.5 ml -20°C
79686 ATP (500 μM) 100 µl -20°C
40560 PI3K lipid substrate
(Packaged separately, Do Not Freeze!)
500 µl +4°C
79696 96-well plate, white 1 Room Temp.  
UniProt #
p110ß: P42338; p85α: P27986
Background
PI3Ks (Phosphatidylinositol 3-kinases) are lipid kinases that phosphorylate PIP2 (phosphatidylinositol 4,5-bisphosphate) to produce PIP3 (phosphatidylinositol 3,4,5-trisphosphate), which plays important roles in fundamental cellular activities such as cell growth, survival, migration, and metabolism. In human cancers, gain-of-function mutations of PI3Ks are found frequently, suggesting that PI3Ks are closely involved in tumorigenesis and that PI3K targeting inhibitors may be promising anticancer drug candidates.
References

Zhao W., et al. Acta Pharmaceutica Sinica B, 7(1): 27-37 (2017)